IR Biosciences Holdings Inc.
IRBS · OTC
12/31/2010 | 12/31/2009 | 12/31/2008 | 12/31/2007 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $280 | $3,158 | $221 |
| + Debt | $3,638 | $6,062 | $6,794 | $0 |
| Enterprise Value | $3,638 | $5,782 | $3,636 | -$221 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$3,568 | -$4,286 | -$5,007 | -$5,501 |
| % Margin | – | – | – | – |
| Net Income | -$5,278 | -$6,463 | -$5,807 | -$5,464 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.31 | -0.49 | -0.49 | -0.5 |
| % Growth | 36.7% | 0% | 2% | – |
| Operating Cash Flow | -$430 | -$2,876 | -$4,769 | -$2,456 |
| Capital Expenditures | -$0 | -$2 | -$20 | -$25 |
| Free Cash Flow | -$430 | -$2,878 | -$4,789 | -$2,481 |